OMM2.5Homo sapiens (Human)Cancer cell line

Also known as: Omm1_5, OMM1.5, OMM25, OMM2_5, Omm2.5

AI Summary

No AI-generated summary available for this cell line.

Basic Information

Database IDCVCL_C307
SpeciesHomo sapiens (Human)
Tissue SourceLiver[UBERON:UBERON_0002107]

Donor Information

Age62
Age CategoryAdult
SexMale

Disease Information

DiseaseUveal melanoma
LineageEye
SubtypeUveal Melanoma
OncoTree CodeUM

DepMap Information

Source TypeAcademic lab
Source IDACH-002018_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleGNAQp.Gln209Pro (c.626A>C)Unspecified-PubMed=32430489

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X,Y
CSF1PO
11
D13S317
12
D16S539
12
D18S51
19
D21S11
28,29
D3S1358
16
D5S818
12
D7S820
8,9
D8S1179
8,13
FGA
26
Penta D
15,16
Penta E
8,10
TH01
6,9
TPOX
10
vWA
17,18
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Uveal melanoma cell lines: where do they come from? (an American Ophthalmological Society thesis).

Jager M.J., Bermudez Magner J.A., Ksander B.R., Dubovy S.R.

Trans. Am. Ophthalmol. Soc. 114:T5-T5(2016).

Establishment of novel cell lines recapitulating the genetic landscape of uveal melanoma and preclinical validation of mTOR as a therapeutic target.

Roman-Roman S.

Mol. Oncol. 8:1508-1520(2014).

Evidence of epidermal growth factor receptor expression in uveal melanoma: inhibition of epidermal growth factor-mediated signalling by gefitinib and cetuximab triggered antibody-dependent cellular cytotoxicity.

Salvi S., Truini M., Poggi A., Pfeffer U.

Eur. J. Cancer 49:3353-3365(2013).

Genetic and molecular characterization of uveal melanoma cell lines.

Bernatchez C., Wardell S., Bastian B.C., Woodman S.E.

Pigment Cell Melanoma Res. 25:182-187(2012).

Expression of MAGE genes in ocular melanoma during progression from primary to metastatic disease.

Ksander B.R.

Clin. Exp. Metastasis 15:509-518(1997).